Citations (79)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Xiaoyun Wu, Qinlan Li, Shanhe Wan & Jiajie Zhang. (2021) Molecular dynamics simulation and free energy calculation studies of the binding mechanism of allosteric inhibitors with TrkA kinase. Journal of Biomolecular Structure and Dynamics 39:1, pages 202-208.
Read now
Read now
Justin J. Bailey, Ralf Schirrmacher, Kristen Farrell & Vadim Bernard-Gauthier. (2017) Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 – Part II. Expert Opinion on Therapeutic Patents 27:7, pages 831-849.
Read now
Read now
Vadim Bernard-Gauthier & Ralf Schirrmacher. (2016) Evaluation of WO2015042088 A1 - a novel urea-based scaffold for TrkA inhibition. Expert Opinion on Therapeutic Patents 26:2, pages 291-295.
Read now
Read now
Clive McCarthy & Edward Walker. (2014) Tropomyosin receptor kinase inhibitors: a patent update 2009 – 2013. Expert Opinion on Therapeutic Patents 24:7, pages 731-744.
Read now
Read now
Servane Tauszig-Delamasure & Jimena Bouzas-Rodriguez. (2011) Targeting neurotrophin-3 and its dependence receptor tyrosine kinase receptor C: a new antitumoral strategy. Expert Opinion on Therapeutic Targets 15:7, pages 847-858.
Read now
Read now
Yasuhiro Indo. (2010) Nerve growth factor, pain, itch and inflammation: lessons from congenital insensitivity to pain with anhidrosis. Expert Review of Neurotherapeutics 10:11, pages 1707-1724.
Read now
Read now
Articles from other publishers (73)
Yuhao Jiao, Ye Tian & Siyi Cai. (2023) From the Destruction of Two Lumbar Segments to Thoracic‐Lumbar‐Pelvic Fusion: A Case Caused by Congenital Insensitivity to Pain with Anhidrosis and Literature Review. Orthopaedic Surgery 15:7, pages 1904-1914.
Crossref
Crossref
Rua M. Mukhtar, Nihal Abdelmoniem, Hisham A. Elrufaie, Alaa Edris, Hiba Ghaboosh, Mohanad A. Mahgoub, Elrashied A. E. Garelnabi, Wadah Osman, Asmaa E. Sherif, Ahmed Ashour, Kholoud F. Ghazawi, Waad A. Samman, Aisha A. Alhaddad, Rawan Bafail, Sabrin R. M. Ibrahim, Gamal A. Mohamed & Abdulrahim A. Alzain. (2023) Unlocking the potential of approved drugs for the allosteric inhibition of tropomyosin-receptor kinase A using molecular docking and molecular dynamics studies. Frontiers in Chemistry 11.
Crossref
Crossref
Carlos Anerillas, Allison B. Herman, Rachel Munk, Amanda Garrido, Kwan-Wood Gabriel Lam, Matthew J. Payea, Martina Rossi, Dimitrios Tsitsipatis, Jennifer L. Martindale, Yulan Piao, Krystyna Mazan-Mamczarz, Jinshui Fan, Chang-Yi Cui, Supriyo De, Kotb Abdelmohsen, Rafael de Cabo & Myriam Gorospe. (2022) A BDNF-TrkB autocrine loop enhances senescent cell viability. Nature Communications 13:1.
Crossref
Crossref
Tabassum Jannat, Md. Jamal Hossain, Ahmed M. El-Shehawi, Md. Ruhul Kuddus, Mohammad A. Rashid, Sarah Albogami, Ibrahim Jafri, Mohamed El-Shazly & Mohammad Rashedul Haque. (2022) Chemical and Pharmacological Profiling of Wrightia coccinea (Roxb. Ex Hornem.) Sims Focusing Antioxidant, Cytotoxic, Antidiarrheal, Hypoglycemic, and Analgesic Properties. Molecules 27:13, pages 4024.
Crossref
Crossref
Elliasu Y. Salifu, Abdul Rashid Issahaku, Clement Agoni, Mahmoud A. A. Ibrahim, Nlooto Manimbulu & Mahmoud E. S. Soliman. (2022) Prioritizing the Catalytic Gatekeepers through Pan- Inhibitory Mechanism of Entrectinib against ALK, ROS1 and TRKA Tyrosine Kinases. Cell Biochemistry and Biophysics 80:1, pages 11-21.
Crossref
Crossref
Shulei Pan, Liting Zhang, Xinling Luo, Jinshan Nan, Wei Yang, Huachao Bin, Yang Li, Qiao Huang, Tianqi Wang, Zhiling Pan, Bo Mu, Falu Wang, Chenyu Tian, Yang Liu, Linli Li & Shengyong Yang. (2022)
Structural Optimization and Structure–Activity Relationship Studies of 6,6-Dimethyl-4-(phenylamino)-6
H
-pyrimido[5,4-
b
][1,4]oxazin-7(8
H
)-one Derivatives as A New Class of Potent Inhibitors of Pan-Trk and Their Drug-Resistant Mutants
. Journal of Medicinal Chemistry 65:3, pages 2035-2058.
Crossref
Crossref
Alfred MalomoJrJr & Daryl I. Smith. 2022. Pathogenesis of Neuropathic Pain. Pathogenesis of Neuropathic Pain
3
25
.
Wei Yan, Lingtian Zhang, Fengping Lv, Marialuisa Moccia, Francesca Carlomagno, Christophe Landry, Massimo Santoro, Fabien Gosselet, Brendan Frett & Hong-yu Li. (2021) Discovery of pyrazolo-thieno[3,2-d]pyrimidinylamino-phenyl acetamides as type-II pan-tropomyosin receptor kinase (TRK) inhibitors: Design, synthesis, and biological evaluation. European Journal of Medicinal Chemistry 216, pages 113265.
Crossref
Crossref
Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han & Chenzhong Liao. (2021) Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. Journal of Medicinal Chemistry 64:3, pages 1283-1345.
Crossref
Crossref
Tingting Jiang, Guan Wang, Yao Liu, Lu Feng, Meng Wang, Jie Liu, Yi Chen & Liang Ouyang. (2021) Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers. Acta Pharmaceutica Sinica B 11:2, pages 355-372.
Crossref
Crossref
Wenjuan Tao, Changmao Chen, Yuping Wang, Wenjie Zhou, Yan Jin, Yu Mao, Haitao Wang, Likui Wang, Wen Xie, Xulai Zhang, Jie Li, Juan Li, Xiangyao Li, Zhen-Quan Tang, Chenghua Zhou, Zhizhong Z. Pan & Zhi Zhang. (2020) MeCP2 mediates transgenerational transmission of chronic pain. Progress in Neurobiology 189, pages 101790.
Crossref
Crossref
Noritaka Furuya, Takaki Momose, Kenji Katsuno, Nobuhiko Fushimi, Hideyuki Muranaka, Chiaki Handa, Masaaki Sawa, Tomonaga Ozawa & Takayoshi Kinoshita. (2020) An isoform-selective inhibitor of tropomyosin receptor kinase A behaves as molecular glue. Bioorganic & Medicinal Chemistry Letters 30:1, pages 126775.
Crossref
Crossref
Govindan Subramanian, Scott J. Bowen, Yaqi Zhu, Nicole Roush, Theresa Zachary, Christopher Javens, Tracey Williams, Ann Janssen & Andrea Gonzales. (2019) Type 2 inhibitor leads of human tropomyosin receptor kinase (hTrkA). Bioorganic & Medicinal Chemistry Letters 29:19, pages 126624.
Crossref
Crossref
Govindan Subramanian, Paul D. Johnson, Theresa Zachary, Nicole Roush, Yaqi Zhu, Scott J. Bowen, Ann Janssen, Brian A. Duclos, Tracey Williams, Christopher Javens, Nancy Dekki Shalaly, Daniel Martinez Molina, Arthur J. Wittwer & Jeffrey L. Hirsch. (2019)
Deciphering the Allosteric Binding Mechanism of the Human Tropomyosin Receptor Kinase A (
h
TrkA) Inhibitors
. ACS Chemical Biology 14:6, pages 1205-1216.
Crossref
Crossref
Hoi Leong Xavier Wong, Hong-yan Qin, Siu Wai Tsang, Xiao Zuo, Sijia Che, Chi Fung Willis Chow, Xi Li, Hai-tao Xiao, Ling Zhao, Tao Huang, Cheng Yuan Lin, Hiu Yee Kwan, Tao Yang, Frank M. Longo, Aiping Lyu & Zhao-xiang Bian. (2019) Early life stress disrupts intestinal homeostasis via NGF-TrkA signaling. Nature Communications 10:1.
Crossref
Crossref
Wei Yan, Naga Rajiv Lakkaniga, Francesca Carlomagno, Massimo Santoro, Neil Q. McDonaldFengping Lv, Naresh Gunaganti, Brendan Frett & Hong-yu Li. (2018) Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application. Journal of Medicinal Chemistry 62:4, pages 1731-1760.
Crossref
Crossref
Sharan K. Bagal, Kiyoyuki OmotoDavid C. BlakemorePeter J. BungayJames G. BilslandPhilip J. ClarkeMatthew S. Corbett, Ciaran N. Cronin, J. Jean Cui, Rebecca DiasNeil J. FlanaganSamantha E. Greasley, Rachel GrimleyEric Johnson, David FengasLinda KitchingMichelle L. Kraus, Indrawan McAlpine, Asako Nagata, Gareth J. WaldronJoseph S. Warmus. (2018) Discovery of Allosteric, Potent, Subtype Selective, and Peripherally Restricted TrkA Kinase Inhibitors. Journal of Medicinal Chemistry 62:1, pages 247-265.
Crossref
Crossref
. 2019. Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 2. Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 2.
David C. Blakemore, Thomas Brandt, Craig Knight & Sarah E. Skerratt. 2019. Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 2. Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 2
155
183
.
Sharan K. Bagal, Mark AndrewsBruce M. Bechle, Jianwei Bian, James BilslandDavid C. BlakemoreJohn F. Braganza, Peter J. BungayMatthew S. Corbett, Ciaran N. Cronin, Jingrong Jean Cui, Rebecca DiasNeil J. FlanaganSamantha E. Greasley, Rachel GrimleyKim JamesEric Johnson, Linda KitchingMichelle L. Kraus, Indrawan McAlpine, Asako Nagata, Sacha Ninkovic, Kiyoyuki OmotoStephanie Scales, Sarah E. SkerrattJianmin Sun, Michelle Tran-Dubé, Gareth J. WaldronFen Wang & Joseph S. Warmus. (2018) Discovery of Potent, Selective, and Peripherally Restricted Pan-Trk Kinase Inhibitors for the Treatment of Pain. Journal of Medicinal Chemistry 61:15, pages 6779-6800.
Crossref
Crossref
Samo Turk, Benjamin Merget, Sameh Eid & Simone Fulle. (2018) From Cancer to Pain Target by Automated Selectivity Inversion of a Clinical Candidate. Journal of Medicinal Chemistry 61:11, pages 4851-4859.
Crossref
Crossref
Juliana Kern de Moraes, Vivian Petersen Wagner, Felipe Paiva Fonseca, Pablo Agustin Vargas, Caroline Brunetto de Farias, Rafael Roesler & Manoela Domingues Martins. (2018) Uncovering the role of brain-derived neurotrophic factor/tyrosine kinase receptor B signaling in head and neck malignancies. Journal of Oral Pathology & Medicine 47:3, pages 221-227.
Crossref
Crossref
Rand Shahin, Iman Mansi, Lubna Swellmeen, Tahani Alwidyan, Nabil Al-Hashimi, Yaser Al-Qarar’h & Omar Shaheen. (2018) Ligand-based computer aided drug design reveals new tropomycin receptor kinase a (TrkA) inhibitors. Journal of Molecular Graphics and Modelling 80, pages 327-352.
Crossref
Crossref
Joseph Shaw, Mathew Leveridge, Charlotta Norling, Jakob Karén, Daniel Martinez Molina, Daniel O’Neill, James E. Dowling, Paul Davey, Suzanna Cowan, Michael Dabrowski, Martin Main & Davide Gianni. (2018) Determining direct binders of the Androgen Receptor using a high-throughput Cellular Thermal Shift Assay. Scientific Reports 8:1.
Crossref
Crossref
Chunze Zhang, Xiaoting Li, Dan Gao, Haihua Ruan, Zhenzhen Lin, Xiaobo Li, Guang Liu, Zhicheng Ma & Xichuan Li. (2017) The prognostic value of over-expressed TrkB in solid tumors: a systematic review and meta-analysis. Oncotarget 8:59, pages 99394-99401.
Crossref
Crossref
Danielle M. Hurzy, Darrell A. Henze, Tamara D. Cabalu, Kartik Narayan, Amanda Heller & Andrew J. Cooke. (2017) Design, synthesis and SAR of substituted indoles as selective TrkA inhibitors. Bioorganic & Medicinal Chemistry Letters 27:12, pages 2695-2701.
Crossref
Crossref
Vahid Heravi Shargh, Hubert Hondermarck & Mingtao Liang. (2017) Gelatin-albumin hybrid nanoparticles as matrix metalloproteinases-degradable delivery systems for breast cancer therapy. Nanomedicine 12:9, pages 977-989.
Crossref
Crossref
L. Li & L. Zhu. (2017) Expression and clinical significance of TrkB in sinonasal squamous cell carcinoma: a pilot study. International Journal of Oral and Maxillofacial Surgery 46:2, pages 144-150.
Crossref
Crossref
Daehyun Kim, Jung Youl Park & Ji-Hyun Kim. (2017)
Docking-based
In Silico
Screening for Identification of Micromolar Inhibitors of Tropomyosin-related Kinase A from Natural Origin
. Bulletin of the Korean Chemical Society 38:2, pages 205-210.
Crossref
Crossref
Hua-Poo SuKeith RickertChristine BurleinKartik NarayanMarina BukhtiyarovaDanielle M. HurzyCraig A. StumpXufang ZhangJohn ReidAlicja Krasowska-ZoladekSrivanya TummalaJennifer M. ShipmanMaria KornienkoPeter A. LemaireDaniel KroskyAmanda HellerAbdelghani Achab, Chad Chamberlin, Peter Saradjian, Berengere Sauvagnat, Xianshu Yang, Michael R. Ziebell, Elliott Nickbarg, John M. SandersMark T. BilodeauSteven S. CarrollKevin J. LumbStephen M. SoissonDarrell A. HenzeAndrew J. Cooke. (2016) Structural characterization of nonactive site, TrkA-selective kinase inhibitors. Proceedings of the National Academy of Sciences 114:3.
Crossref
Crossref
Bryan H. Norman & Jeff S. McDermott. (2016) Targeting the Nerve Growth Factor (NGF) Pathway in Drug Discovery. Potential Applications to New Therapies for Chronic Pain. Journal of Medicinal Chemistry 60:1, pages 66-88.
Crossref
Crossref
Mohammad Sayed Alam, Sang-Un Choi & Dong-Ung Lee. (2017) Synthesis, anticancer, and docking studies of salicyl-hydrazone analogues: A novel series of small potent tropomyosin receptor kinase A inhibitors. Bioorganic & Medicinal Chemistry 25:1, pages 389-396.
Crossref
Crossref
T. Bertrand. 2017. Neurotrophins. Neurotrophins
1
18
.
Vahid Heravi Shargh, Hubert Hondermarck & Mingtao Liang. (2016) Albumin hybrid nanoparticles loaded with tyrosine kinase A inhibitor GNF-5837 for targeted inhibition of breast cancer cell growth and invasion. International Journal of Pharmaceutics 515:1-2, pages 527-534.
Crossref
Crossref
Sarah E. SkerrattMark AndrewsSharan K. BagalJames BilslandDavid BrownPeter J. BungaySusan ColeKarl R GibsonRussell JonesInaki MoraoAngus NeddermanKiyoyuki OmotoColin RobinsonThomas RyckmansKimberly SkinnerPaul StuppleGareth Waldron. (2016) The Discovery of a Potent, Selective, and Peripherally Restricted Pan-Trk Inhibitor (PF-06273340) for the Treatment of Pain. Journal of Medicinal Chemistry 59:22, pages 10084-10099.
Crossref
Crossref
Jaana Tammiku-Taul, Rahel Park, Kaur Jaanson, Kristi Luberg, Dimitar A. Dobchev, Dzmitry Kananovich, Artur Noole, Merle Mandel, Allen Kaasik, Margus Lopp, Tõnis Timmusk & Mati Karelson. (2016) Indole-like Trk receptor antagonists. European Journal of Medicinal Chemistry 121, pages 541-552.
Crossref
Crossref
Andrea Wolkerstorfer, Norbert Handler & Helmut Buschmann. (2016) New approaches to treating pain. Bioorganic & Medicinal Chemistry Letters 26:4, pages 1103-1119.
Crossref
Crossref
Maud Antoine, Tilmann Schuster, Irene Seipelt, Babette Aicher, Michael Teifel, Eckhard Günther, Matthias Gerlach & Pascal Marchand. (2016) Efficient synthesis of novel disubstituted pyrido[3,4-b]pyrazines for the design of protein kinase inhibitors. MedChemComm 7:2, pages 224-229.
Crossref
Crossref
Vadim Bernard-Gauthier, Justin J. Bailey, Arturo Aliaga, Alexey Kostikov, Pedro Rosa-Neto, Melinda Wuest, Garrett M. Brodeur, Barry J. Bedell, Frank Wuest & Ralf Schirrmacher. (2015)
Development of subnanomolar radiofluorinated (2-pyrrolidin-1-yl)imidazo[1,2-
b
]pyridazine pan-Trk inhibitors as candidate PET imaging probes
. MedChemComm 6:12, pages 2184-2193.
Crossref
Crossref
Léo Aubert, Matthieu Guilbert, Cyril Corbet, Elisabeth Génot, Eric Adriaenssens, Thierry Chassat, François Bertucci, Thomas Daubon, Nicolas Magné, Xuefen Le Bourhis & Robert-Alain Toillon. (2015) NGF-induced TrkA/CD44 association is involved in tumor aggressiveness and resistance to lestaurtinib. Oncotarget 6:12, pages 9807-9819.
Crossref
Crossref
Vadim Bernard-Gauthier, Arturo Aliaga, Antonio Aliaga, Mehdi Boudjemeline, Robert Hopewell, Alexey Kostikov, Pedro Rosa-Neto, Alexander Thiel & Ralf Schirrmacher. (2014) Syntheses and Evaluation of Carbon-11- and Fluorine-18-Radiolabeled pan-Tropomyosin Receptor Kinase (Trk) Inhibitors: Exploration of the 4-Aza-2-oxindole Scaffold as Trk PET Imaging Agents. ACS Chemical Neuroscience 6:2, pages 260-276.
Crossref
Crossref
Melissa T. Manners, Yuzhen Tian, Zhaolan Zhou & Seena K. Ajit. (2015) MicroRNAs downregulated in neuropathic pain regulate MeCP2 and BDNF related to pain sensitivity. FEBS Open Bio 5:1, pages 733-740.
Crossref
Crossref
Zongli Zheng, Matthew Liebers, Boryana Zhelyazkova, Yi Cao, Divya Panditi, Kerry D Lynch, Juxiang Chen, Hayley E Robinson, Hyo Sup Shim, Juliann Chmielecki, William Pao, Jeffrey A Engelman, A John Iafrate & Long Phi Le. (2014) Anchored multiplex PCR for targeted next-generation sequencing. Nature Medicine 20:12, pages 1479-1484.
Crossref
Crossref
Vadim Bernard-Gauthier & Ralf Schirrmacher. (2014) 5-(4-((4-[18F]fluorobenzyl)oxy)-3-methoxybenzyl)pyrimidine-2,4-diamine: A selective dual inhibitor for potential PET imaging of Trk/CSF-1R. Bioorganic & Medicinal Chemistry Letters 24:20, pages 4784-4790.
Crossref
Crossref
Julien Defaux, Maud Antoine, Cédric Logé, Marc Le Borgne, Tilmann Schuster, Irene Seipelt, Babette Aicher, Michael Teifel, Eckhard Günther, Matthias Gerlach & Pascal Marchand. (2014) Discovery of (7-aryl-1,5-naphthyridin-2-yl)ureas as dual inhibitors of ERK2 and Aurora B kinases with antiproliferative activity against cancer cells. Bioorganic & Medicinal Chemistry Letters 24:16, pages 3748-3752.
Crossref
Crossref
Shawn J. Stachel, John M. Sanders, Darrell A. Henze, Mike T. Rudd, Hua-Poo Su, Yiwei Li, Kausik K. Nanda, Melissa S. Egbertson, Peter J. Manley, Kristen L. G. Jones, Edward J. Brnardic, Ahren Green, Jay A. Grobler, Barbara Hanney, Michael Leitl, Ming-Tain Lai, Vandna Munshi, Dennis Murphy, Keith Rickert, Daniel Riley, Alicja Krasowska-Zoladek, Christopher Daley, Paul Zuck, Stephanie A. Kane & Mark T. Bilodeau. (2014) Maximizing Diversity from a Kinase Screen: Identification of Novel and Selective pan-Trk Inhibitors for Chronic Pain. Journal of Medicinal Chemistry 57:13, pages 5800-5816.
Crossref
Crossref
Lei Zeng, Miklos Kuti, Shiraz Mujtaba & Ming-Ming Zhou. (2014) Structural insights into FRS2α PTB domain recognition by neurotrophin receptor TrkB. Proteins: Structure, Function, and Bioinformatics 82:7, pages 1534-1541.
Crossref
Crossref
Giusi Prencipe, Gaetana Minnone, Raffaele Strippoli, Loredana De Pasquale, Stefania Petrini, Ivan Caiello, Luigi Manni, Fabrizio De Benedetti & Luisa Bracci-Laudiero. (2014) Nerve Growth Factor Downregulates Inflammatory Response in Human Monocytes through TrkA. The Journal of Immunology 192:7, pages 3345-3354.
Crossref
Crossref
Brendan Frett, Nick McConnell, Yuanxiang Wang, Zhigang Xu, Andrew Ambrose & Hong-yu Li. (2014) Identification of pyrazine-based TrkA inhibitors: design, synthesis, evaluation, and computational modeling studies. Med. Chem. Commun. 5:10, pages 1507-1514.
Crossref
Crossref
Julien Defaux, Maud Antoine, Marc Le Borgne, Tilmann Schuster, Irene Seipelt, Babette Aicher, Michael Teifel, Eckhard Günther, Matthias Gerlach & Pascal Marchand. (2013) Discovery of 7‐Aryl‐Substituted (1,5‐Naphthyridin‐4‐yl)ureas as Aurora Kinase Inhibitors. ChemMedChem 9:1, pages 217-232.
Crossref
Crossref
Grazia Pula, Alessandra Pistilli, Claudia Montagnoli, Anna M. Stabile, Maria G. Rambotti & Mario Rende. (2013) The tricyclic antidepressant amitriptyline is cytotoxic to HTB114 human leiomyosarcoma and induces p75NTR-dependent apoptosis. Anti-Cancer Drugs 24:9, pages 899-910.
Crossref
Crossref
S V Ivanov, A Panaccione, B Brown, Y Guo, C A Moskaluk, M J Wick, J L Brown, A V Ivanova, N Issaeva, A K El-Naggar & W G Yarbrough. (2012) TrkC signaling is activated in adenoid cystic carcinoma and requires NT-3 to stimulate invasive behavior. Oncogene 32:32, pages 3698-3710.
Crossref
Crossref
Andrei Leitão, Alexander Schramm & Angelika Eggert. (2013) Discovery of a New Bioactive Molecule for Neuroblastoma. Chemical Biology & Drug Design 82:2, pages 233-241.
Crossref
Crossref
Pontus Forsell, Helena Almqvist, Per Hillertz, Tomas Åkerud, Magdalena Otrocka, Lina Eisele, Kai Sun, Henrik Andersson, Shephali Trivedi, Anna Ridderstad Wollberg, Niek Dekker, Didier Rottici & Kristian Sandberg. (2013) The Use of TrkA-PathHunter Assay in High-Throughput Screening to Identify Compounds That Affect Nerve Growth Factor Signaling. SLAS Discovery 18:6, pages 659-669.
Crossref
Crossref
Joel T. Arcari, Jean S. Beebe, Martin A. Berliner, Vincent Bernardo, Merin Boehm, Gary V. Borzillo, Tracey Clark, Bruce D. Cohen, Richard D. Connell, Heather N. Frost, Deborah A. Gordon, William M. Hungerford, Shefali M. Kakar, Aaron Kanter, Nandell F. Keene, Elizabeth A. Knauth, Susan D. LaGreca, Yong Lu, Louis Martinez-Alsina, Matthew A. Marx, Joel Morris, Nandini C. Patel, Doug Savage, Cathy I. Soderstrom, Carl Thompson, George Tkalcevic, Norma J. Tom, Felix F. Vajdos, James J. Valentine, Patrick W. Vincent, Matthew D. Wessel & Jinshan M. Chen. (2013) Discovery and synthesis of novel 4-aminopyrrolopyrimidine Tie-2 kinase inhibitors for the treatment of solid tumors. Bioorganic & Medicinal Chemistry Letters 23:10, pages 3059-3063.
Crossref
Crossref
Ji Yea Kim, Chun Jeih Ryu & Hwangseo Park. (2013) Effects of Tropomyosin-Related Kinase A Inhibitors on the Proliferation of Human Lung Cancer Cells. Bulletin of the Korean Chemical Society 34:4, pages 1293-1295.
Crossref
Crossref
Megan Crow, Franziska Denk & Stephen B McMahon. (2013) Genes and epigenetic processes as prospective pain targets. Genome Medicine 5:2, pages 12.
Crossref
Crossref
Lisa A. Cannon-Albright, Craig C. Teerlink, James M. Farnham, Alun W. Thomas, John J. Zone & Sancy A. Leachman. (2013) Linkage Analysis of Extended High-Risk Pedigrees Replicates a Cutaneous Malignant Melanoma Predisposition Locus on Chromosome 9q21. Journal of Investigative Dermatology 133:1, pages 128-134.
Crossref
Crossref
Kirsty J. Martin & J. Simon C. Arthur. (2012) Selective kinase inhibitors as tools for neuroscience research. Neuropharmacology 63:7, pages 1227-1237.
Crossref
Crossref
Hubert Hondermarck. (2012) Neurotrophins and their receptors in breast cancer. Cytokine & Growth Factor Reviews 23:6, pages 357-365.
Crossref
Crossref
T. Bertrand, M. Kothe, J. Liu, A. Dupuy, A. Rak, P.F. Berne, S. Davis, T. Gladysheva, C. Valtre, J.Y. Crenne & M. Mathieu. (2012) The Crystal Structures of TrkA and TrkB Suggest Key Regions for Achieving Selective Inhibition. Journal of Molecular Biology 423:3, pages 439-453.
Crossref
Crossref
Seunghee Hong, Jinhee Kim, Ju Hyeon Seo, Kyung Hee Jung, Soon-Sun Hong & Sungwoo Hong. (2012) Design, Synthesis, and Evaluation of 3,5-Disubstituted 7-Azaindoles as Trk Inhibitors with Anticancer and Antiangiogenic Activities. Journal of Medicinal Chemistry 55:11, pages 5337-5349.
Crossref
Crossref
Stéphane L. Raeppel, Frédéric Gaudette, Hannah Nguyen, Normand Beaulieu, James Wang, Christiane Maroun, Jeffrey M. Besterman & Arkadii Vaisburg. (2012) Identification of a Novel Series of Potent TrkA Receptor Tyrosine Kinase Inhibitors. International Journal of Medicinal Chemistry 2012, pages 1-6.
Crossref
Crossref
Pam Albaugh, Yi Fan, Yuan Mi, Fangxian Sun, Francisco Adrian, Nanxin Li, Yong Jia, Yelena Sarkisova, Andreas Kreusch, Tami Hood, Min Lu, Guoxun Liu, Shenlin Huang, Zuosheng Liu, Jon Loren, Tove Tuntland, Donald S. Karanewsky, H. Martin Seidel & Valentina Molteni. (2012) Discovery of GNF-5837, a Selective TRK Inhibitor with Efficacy in Rodent Cancer Tumor Models. ACS Medicinal Chemistry Letters 3:2, pages 140-145.
Crossref
Crossref
Hwangseo Park, Okyung Chi, Jinhee Kim & Sungwoo Hong. (2011) Identification of Novel Inhibitors of Tropomyosin-Related Kinase A through the Structure-Based Virtual Screening with Homology-Modeled Protein Structure. Journal of Chemical Information and Modeling 51:11, pages 2986-2993.
Crossref
Crossref
Sibel Avcuoglu, Małgorzata Wygrecka, Leigh M. Marsh, Andreas Günther, Werner Seeger, Norbert Weissmann, Ludger Fink, Rory E. Morty & Grażyna Kwapiszewska. (2011) Neurotrophic Tyrosine Kinase Receptor B/Neurotrophin 4 Signaling Axis Is Perturbed in Clinical and Experimental Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology 45:4, pages 768-780.
Crossref
Crossref
Aditi A. Bapat, Galen Hostetter, Daniel D. Von Hoff & Haiyong Han. (2011) Perineural invasion and associated pain in pancreatic cancer. Nature Reviews Cancer 11:10, pages 695-707.
Crossref
Crossref
Ray Hill. (2011) Blocking the effects of NGF as a route to safe and effective pain relief – fact or fancy?. Pain 152:10, pages 2200-2201.
Crossref
Crossref
Kirsty J. Martin, Natalia Shpiro, Ryan Traynor, Matthew Elliott & J. Simon C. Arthur. (2011) Comparison of the specificity of Trk inhibitors in recombinant and neuronal assays. Neuropharmacology 61:1-2, pages 148-155.
Crossref
Crossref
Jörn Lötsch & Gerd Geisslinger. (2011) Pharmacogenetics of new analgesics. British Journal of Pharmacology 163:3, pages 447-460.
Crossref
Crossref
Philippe G. Nantermet & Darrell A. Henze. 2011.
19
32
.
Črtomir Podlipnik, Federico Tutino, Anna Bernardi & Pierfausto Seneci. (2010) DFG-in and DFG-out homology models of TrkB kinase receptor: Induced-fit and ensemble docking. Journal of Molecular Graphics and Modelling 29:3, pages 309-320.
Crossref
Crossref
. (2010) Current World Literature. Current Opinion in Supportive & Palliative Care 4:1, pages 46-51.
Crossref
Crossref